Hepatitis C virus (HCV) is an important cause of morbidity and mortality worldwide, causing a spectrum of disease ranging from an asymptomatic carrier state to end-stage liver disease. The most important feature of persistent HCV infection is the development of chronic hepatitis in more than 50 % of infected individuals and the potential for disease progression to cirrhosis and hepatocellular carcinoma (Saito et al., 1990; Alter, 1995; Kiyosawa & Tanaka, 2002; Koike et al., 2000) . Although limited replication of HCV occurs in some mammalian cells, successful purification of HCV has not been reported. It is therefore difficult to study the biological properties and pathogenicity of HCV. The virus genome contains a linear, positive-strand RNA molecule of~9500 nt and encodes a single polyprotein precursor of~3000 aa (Choo et al., 1989) . This polyprotein is cleaved by both host and viral proteases (Grakoui et al., 1993; Hijikata et al., 1991) , generating at least 10 individual proteins, the core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B. The core protein is located between aa 1 and 191 of the HCV polypeptide (Clarke, 1997) .
The core protein may be the fundamental unit for encapsidation of genomic RNA to help in virus assembly. However, it has many intriguing properties. The core protein transcriptionally regulates a number of cellular promoters (Bergqvist & Lee et al., 2002; McLauchlan, 2000; Ray et al., 1995a Ray et al., , 1997 Ray et al., , 1998b Srinivas et al., 1996; Shrivastava et al., 1998; Yoshida et al., 2002) . Since the core protein does not appear to bind DNA directly, the mechanism of transcriptional regulation remains to be elucidated. The HCV core protein protects against apoptosis mediated by c-myc in Chinese hamster ovarian cells and in tumour necrosis factor alpha (TNF-a)-sensitive human breast carcinoma (MCF7) and human hepatoma (HepG2) cells (Marusawa et al., 1999; Ray et al., 1998a; Shrivastava et al., 1998) . Functional involvement of the core protein in cell growth regulation was indicated from studies with primary human hepatocytes and rodent cells Chang et al., 1998; Tsuchihara et al., 1999) . The HCV core protein leads to the development of hepatocellular carcinoma in transgenic mice (Moriya et al., 1998) Vassilaki & Mavromara, 2003) . In this study we investigated the functional role of the~16 kDa protein (named F/ARFP/core+1 ORF) generated by a ribosomal frameshift between codons 8 and 11 of the HCV core-encoding genomic region (Xu et al., 2001; Walewski et al., 2001; Varaklioti et al., 2002) . The functional significance of this viral F protein remains unknown. It is a short-lived endoplasmic reticulum-associated protein (Roussel et al., 2003; Xu et al., 2003) and does not appear to play a major role in HCV replication because the subgenomic replicons, lacking the structural region of HCV, efficiently replicate in Huh-7 cells. This indicates that the structural proteins and, by consequence, the F protein are dispensable for HCV RNA replication (Gosert & Moradpour, 2002) . The HCV core genomic region has the potential for generating smaller polypeptides by frameshifting or from an internal initiation codon Boulant et al., 2003; Vassilaki & Mavromara, 2003) . However, their expression in mammalian cells and functional relevance in HCV replication and pathogenesis remains to be elucidated. For simplicity, we will refer to the core as the protein product from nt 342 to 913 of genotype 1a (GenBank accession no. M62321).
Identification of the F protein raises the question as to which of the two proteins -the F or the core proteinencoded by the core genomic region from HCV genotype 1a is responsible for the previously observed functions (Ray & Ray, 2001) . In this study, we examined the functions of the F protein compared with those from the HCV core genomic region. These results provided us with further insight into the functional properties of the F protein.
A partial cDNA clone (Blue4/C5p-1) of HCV genotype 1a containing the 59-untranslated region, the core, E1, E2, p7 genes and a portion of the NS2 region (kindly provided by Michael Houghton, Chiron Corporation, Emeryville, CA, USA) was used as a template for amplification and cloning of the desired genomic regions. Different lengths of HCV core gene constructs, including portions of the structural regions of HCV, have been used by other investigators for understanding the processing and the functional role of the HCV core protein. Since we have used an HCV 1a core construct-encoding protein from aa 1 to 191 in most of our previous work, the same gene construct was made in this study with an N-terminal Flag tag for comparison of function with the F protein (Fig. 1a) . The core genomic region was synthesized by PCR from Blue4/C5p-1 using sense (59-CGTAGACCGGGATCCTGAGCACGAA-39, containing a BamHI restriction site) and antisense (59-GAA-GCGGGTCTAGAGCAAGCAAGA-39, containing an XbaI site) primers and cloned in-frame into the pcDNA3-Flag mammalian expression vector (Ghosh et al., 2003) . The F gene was amplified by PCR using sense (59-GCACCGG-ATCCATGAGCACGAATCCTAAACCTCAAAAAAAAACA-39, containing a BamHI site) and antisense (59-CCTGT-TCTAGAGTTCACGCCGTC-39, containing an XbaI site) primers. The amplified DNA was cloned in-frame into pcDNA3-Flag. This gene construct contained 10 aa from the core sequence followed by the +1 reading frame.
For in vivo expression, the N-terminally Flag-tagged core gene was expressed transiently in HepG2 cells using a recombinant vaccinia virus T7 polymerase system. After 24 h transfection, the cells were harvested and lysed for Western blot analysis. An anti-Flag murine monoclonal antibody (Sigma) or rabbit antiserum to an HCV core fusion peptide (aa 1-59 fused to GST, kindly provided by Arvind Patel, University of Glasgow, UK) was used as the primary antibody. An anti-mouse or anti-rabbit immunoglobulin coupled to horseradish peroxidase was used as the secondary antibody for detection of the viral proteins by chemiluminescence (ECL; Amersham). Western blot analysis using an anti-Flag antibody displayed expression of both~21 kDa (core) and~16 kDa (F) protein bands from the two ORFs of the HCV core genomic region (Fig. 1b) . We also made a core mutant called core (9mt), mutated at aa 9 , and cloned this in-frame with the Flag tag into the pcDNA3 vector. For this construct, we mutated KRR at codon 9, which abolishes the synthesis of the F protein (Fig. 1b) . We did not observe expression of a smaller peptide from this mutant Flagcore construct, possibly because the smaller-sized protein was not detectable on the gel because of its size or because the ORF does not share the same methionine as the core protein. Western blot analysis using a rabbit antiserum to the core protein displayed expression of the HCV core protein only as a 21 kDa band (Fig. 1c) . Therefore, our results suggested that both the 16 kDa and 21 kDa polypeptides are synthesized from the HCV core genomic region when transfected into mammalian cells.
We have observed previously that the HCV core protein has transregulatory properties against cellular genes. To examine whether the transregulatory effect occurs via the core or the F protein, we investigated the functional role of the F protein in transcriptional modulation of the cellular promoters c-myc, hTERT, p53 and p21. HepG2 cells were co-transfected with the F gene and the cellular promoter fused with the appropriate reporter gene as described previously (Ray et al., 1995a) . Empty vector DNA was used as a negative control for comparison. The total amount of DNA was kept constant in the transfection mixture by the addition of empty vector. Cytomegalovirus b-galactosidase was used as an internal control in determining transfection efficiency. A comparable number (<20 % variation) of blue transfected cells expressing b-galactosidase was observed, suggesting a similar level of transfection efficiency. CAT or luciferase assays were performed at 48 h post-transfection to analyse changes in cellular gene expression. When cells were co-transfected with a human c-myc-CAT reporter construct and different effector plasmid DNAs, the HCV core gene or core (9mt) mutant enhanced CAT activity approximately fivefold from the human c-myc promoter, compared with the vector control (Fig. 2a) . This enhancement was observed to be dose-dependent (data not shown) as reported previously (Ray et al., 1995a) . On the other hand, transfection with the F gene displayed approximately twofold higher c-myc promoter activity and this modulation was not observed to occur in a dose-dependent manner over a range of 1-10 mg F plasmid DNA (data not shown). We have shown in a previous study that the N-terminal region of the core protein may play a role in c-myc promoter activation (Ray et al., 1995a) . The lack of c-myc activation by the F protein suggested that the N-terminal 10 aa, present in both the core and F proteins, are not involved in c-myc activation. Thus, the F protein did not appear to modulate c-myc promoter activity significantly, as was observed with the HCV core protein.
Since the core protein upregulates the hTERT promoter (Basu et al., 2002) , we examined whether the F protein plays a role in transcriptional modulation of hTERT. Cells were co-transfected with HCV F or core protein and an hTERT-luciferase reporter construct comprising~800 bp of upstream sequence from the translation start site of hTERT gene. Analysis of luciferase activity in the cell lysates suggested that the F protein, unlike the HCV core or core 9mt, did not alter hTERT promoter activity (Fig. 2b) .
We next analysed whether the F protein modulates p53 promoter activity, as has been shown for the HCV core protein (Ray et al., 1997) . HepG2 cells were co-transfected with a plasmid containing the human p53 promoter linked to the CAT reporter gene (p53-CAT) plus F plasmid DNA or empty vector DNA as a negative control. Core plasmid DNA was used in a similar co-transfection assay for comparison. Our results suggested that the F protein does not play a significant role in modulation of the p53 promoter (Fig. 3a) . In contrast, a reduction in p53 promoter activity was observed in the presence of the core gene. Thus, the results suggested that repression of p53 promoter activity was attributable to exogenous expression of the HCV core protein, but not the F protein.
We have shown previously that the HCV core genomic region represses p21 promoter activity in a p53-independent manner (Ray et al., 1998b) . To determine the effect of F protein expression, HepG2 cells were co-transfected with a human p21 promoter linked to the luciferase gene as the reporter construct together with core, core (9mt) or F plasmid DNA as the effector construct, using lipofectamine (Invitrogen). Introduction of the F gene into HepG2 cells significantly repressed p21 promoter activity (Fig. 3b) . Core or core (9mt) protein expression also displayed repression of p21 promoter activity. The protein expression levels of p21 following core or F protein expression in HepG2 cells were also determined by Western blot analysis. Results suggested an approximately fourfold and 2?5-fold lower level of p21 in cells expressing core or F protein, respectively, compared with vector control cells (Fig. 3c) . Repression of p21 transcription following HCV core gene expression from genotype 1b has also been observed by other investigators (Lee et al., 2002; Nguyen et al., 2003) and has been implicated as a mechanism of oncogene-mediated growth promotion. Thus, the transcriptional repression of the p21 promoter by the HCV F protein may promote cell growth.
TNF-a plays an important role in controlling viral infection. We and others have shown that the core protein protects against TNF-a-mediated apoptosis (Ray et al., 1998a; Marusawa et al., 1999) . In this study, the role of the F protein on TNF-a-induced apoptosis was investigated. HepG2 cells were stably transfected with F plasmid DNA and cells were pooled to avoid artefacts arising from clonal analysis. We have shown previously that TNF-a treatment (20 ng ml
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) of HepG2 cells induces apoptosis in the absence of actinomycin D (Ghosh et al., 2000) and that the HCV core protein protects against TNF-a-mediated cell death (Ray et al., 1998a) . TNF-a treatment of empty vectoror F-transfected HepG2 cells for 24 h induced a fivefold increase in DNA fragmentation, as measured using a cell death ELISA kit (Roche), while cells expressing the HCV core protein inhibited DNA fragmentation (Fig. 4a) . These results suggested that the HCV core protein protected cells from TNF-a-mediated apoptosis. However, HepG2 cells expressing the F protein displayed levels of cell death similar to the vector-transfected cells. Thus, the F protein did not appear to inhibit TNF-a-induced HepG2 cell death. et al., 1981) were transfected with core, F or vector control plasmid DNA. Forty-eight hours post-transfection, cells were split at a 1 : 9 dilution, G418 (800 mg ml
Early-passaged rat embryo fibroblast (REF 52) cells (Logan
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) was added for neomycin gene selection and cells were selected for 3 weeks (Ray et al., 1995b) . Stable transfectants of REF 52 cells were pooled to avoid clonal artefacts and examined for growth. Transfected cells were morphologically indistinguishable. To determine the growth rate, an equal number of cells were plated and cell number was determined by trypan blue exclusion. Cell growth was also measured at 24 h intervals for 5 days using the CellTitre 96 aqueous non-radioactive cell proliferation assay (Promega). Cells were quantified from the formazan produced relative to blanks without cells. Relative cell numbers were determined as described previously (Spanjaard et al., 1997) . Results from three independent experiments suggested that cells into which the F gene had been introduced had similar growth properties to vector-transfected cells, while coretransfected REF 52 cells displayed at least a twofold higher growth rate. Therefore, F protein expression did not appear to play a role in REF 52 cell growth modulation.
In conclusion, we have investigated the expression of the F protein in vivo and whether it shared some of the previously characterized activities of the HCV core protein.
Similar observations were noted with and without the Flag tag in F or core gene constructs. Our results suggested that the F protein does not share the major functional properties identified previously for the HCV core protein and implicated in cell growth regulation. However, we do not rule out the possibility of functional activities of the protein(s) generated from other alternative reading frames of the HCV core genomic region; this will require further investigation. We previously observed transcriptional repression of p21 with the core genomic region from HCV genotype 1a (Ray et al., 1998b) . Recently, Yamanaka et al. (2002) reported that core protein expression in the nucleus decreased the amount of p21 by the p53-independent pathway. A different study (Nguyen et al., 2003) also demonstrated that the mature form of the core protein inhibited p21 expression.
The F protein was not found in all HCV genomes available in GenBank. Translation of the F protein is easily detected by in vitro translation and transfection assays in some HCV isolates. Although seroconversion against the F protein in HCV-infected individuals has been reported (Walewski et al., 2001; Varaklioti et al., 2002) , rabbit antiserum to a core fusion peptide (aa 1-59 fused to GST) did not recognize the F protein, implying that the first 10 aa of the core and F proteins do not constitute an antigenic site. Taken together, our results suggest that the F protein does not share the major functional roles of the core protein, except for modulation of the p21 gene. Therefore, the biological function of the F protein merits further investigation, especially with regard to its regulatory role on p21 promoter activity. 
